- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: EGFR sensitive mutation
Total 4956 results
-
Spectrum Pharmaceuticals, IncTerminated
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
National Cancer Centre, SingaporeCompletedNon-small Cell Lung CancerSingapore
-
AstraZenecaiOMEDICO AG, Freiburg, GermanyCompletedCarcinoma, Non-Small-Cell LungGermany
-
European Organisation for Research and Treatment...Active, not recruitingEGFR Mutation Positive Non Small Cell Lung CancerUnited Kingdom
-
Sun Yat-sen UniversityEnrolling by invitation
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | EGFR Activating MutationUnited States
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerUnited States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
Hellenic Cooperative Oncology GroupCompletedNon Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Gene Mutation
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
Shandong Cancer Hospital and InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownNon Small Cell Lung CancerChina
-
Hanmi Pharmaceutical Company LimitedTerminatedNSCLCKorea, Republic of, China
-
Fudan UniversityUnknownLung Cancer, Non-small Cell | EGFR Gene Mutation | EGFR T790MChina
-
PfizerCompletedSolid Tumor | Unspecified Adult Solid Tumor, Protocol SpecificUnited States, Australia, Canada, France, Spain
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedLung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7 | EGFR Exon 19 Deletion Mutation | EGFR NP_005219.2:p.L858RUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Shanghai Cancer Hospital, ChinaUnknownLung Cancer Stage IV,EGFR-mutant,TKI,PD-L1,SBRTChina
-
Qilu Pharmaceutical Co., Ltd.UnknownNon-small-cell Lung CancerChina
-
Ahon Pharmaceutical Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesUnknown
-
Massachusetts General HospitalYale University; Genentech, Inc.; Stanford University; University of Maryland,...UnknownNon-small Cell Lung CancerUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkUnknown
-
Samsung Medical CenterCompletedMetastatic Breast CancerKorea, Republic of
-
Henan Cancer HospitalUnknownLung AdenocarcinomaChina
-
AstraZenecaCompletedNon-Small Cell Lung CancerRussian Federation
-
Royal Cornwall Hospitals TrustBiocartisCompletedAdenocarcinoma of LungUnited Kingdom
-
Chinese University of Hong KongPamela Youde Nethersole Eastern HospitalCompleted
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal MetastasisChina
-
AstraZenecaCompleted
-
Fuda Cancer Hospital, GuangzhouCompletedLung Neoplasms
-
AbbVieEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedGlioblastomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Singapore, Spain, Switzerland, Taiwan, United Kingdom
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Gene MutationChina
-
Haihe Biopharma Co., Ltd.UnknownNegative T790M Mutation and Met AmplificationChina
-
Boehringer IngelheimCompletedLung NeoplasmsHong Kong, Korea, Republic of, Spain, Singapore, China, United Kingdom, Taiwan, Canada, Australia, Germany, Ireland, Sweden, France, Norway
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell Lung | ErbB ReceptorsUnited States
-
Cancer Institute and Hospital, Chinese Academy...UnknownNon Small Cell Lung Cancer | Stage III Non-small-cell Lung Cancer | EGFR Mutation-Related Tumors
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerItaly, Singapore, Spain, Germany, Korea, Republic of, United States, Belgium, France, Netherlands, Japan
-
Guangdong Association of Clinical TrialsPeking University First Hospital; Zhejiang Cancer Hospital; Peking University... and other collaboratorsUnknownNon-small Cell Lung CancerChina
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell Lung With EGFR Mutation PositiveChina
-
Changi General HospitalCompleted
-
Geneplus-Beijing Co. Ltd.Shanghai Chest HospitalCompletedLung Neoplasms | Adenocarcinoma of Lung | Lung Cancer, Nonsmall Cell | Squamous Cell Lung CancerChina
-
Centre Georges Francois LeclercAstraZenecaTerminatedNon-small Cell Lung Cancer MetastaticFrance
-
Centre Georges Francois LeclercCompletedCarcinoma, Non-Small-Cell LungFrance
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungGermany
-
Novartis PharmaceuticalsWithdrawnLeukemia, Myeloid, Acute
-
Allist Pharmaceuticals, Inc.UnknownLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung CancerChina
-
Allist Pharmaceuticals, Inc.Unknown
-
Shenzhen Fifth People's HospitalUnknownNK Cell Mediated ImmunityChina